As of 2024-12-15, the Relative Valuation of Horizon Therapeutics PLC (HZNP) is 40.47 USD. This relative valuation is based on P/E multiples. With the latest stock price at 116.30 USD, the upside of Horizon Therapeutics PLC based on Relative Valuation is -65.2%.
The range of the Relative Valuation is 30.72 - 55.14 USD.
| Range | Selected | |
| Trailing P/E multiples | 17.6x - 26.3x | 21.7x |
| Forward P/E multiples | 13.4x - 24.0x | 17.2x |
| Fair Price | 30.72 - 55.14 | 40.47 |
| Upside | -73.6% - -52.6% | -65.2% |
| Date | P/E |